Cytori Therapeutics Inc Stock Nasdaq
Equities
US23283K4022
Biotechnology & Medical Research
Sales 2024 * | 5.08M 6.95M | Sales 2025 * | 2.87M 3.92M | Capitalization | 9.24M 12.64M |
---|---|---|---|---|---|
Net income 2024 * | -21M -28.73M | Net income 2025 * | -29M -39.67M | EV / Sales 2024 * | 1.82 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.22 x |
P/E ratio 2024 * |
-0.9
x | P/E ratio 2025 * |
-0.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.77% |
Latest transcript on Cytori Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 20-02-05 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Richard Hawkins
CHM | Chairman | 75 | 07-11-30 |
Robert Lenk
BRD | Director/Board Member | 75 | 20-02-29 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |